Matches in Wikidata for { <http://www.wikidata.org/entity/Q64716067> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q64716067 description "clinical trial" @default.
- Q64716067 description "ensayu clínicu" @default.
- Q64716067 description "klinisch onderzoek" @default.
- Q64716067 description "клінічне випробування" @default.
- Q64716067 description "կլինիկական փորձարկում" @default.
- Q64716067 name "Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia" @default.
- Q64716067 type Item @default.
- Q64716067 label "Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia" @default.
- Q64716067 prefLabel "Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia" @default.
- Q64716067 P1050 Q64716067-A4AA66C4-022A-40EB-B3EA-4EF6AFABF8C9 @default.
- Q64716067 P1132 Q64716067-CA88B4B6-98FF-4F3E-AEB3-AA2F1161573A @default.
- Q64716067 P1476 Q64716067-F3E5FC1D-388B-47FE-9737-D9F3B6FF324A @default.
- Q64716067 P17 Q64716067-08FC31D3-DDCB-46D0-88F7-B71EE4E55C39 @default.
- Q64716067 P1813 Q64716067-0FF35166-EB55-4ADD-9148-A9E2D8473785 @default.
- Q64716067 P2899 Q64716067-2C4D3BE3-5B38-4502-ABDB-54B1FADEA3FE @default.
- Q64716067 P3098 Q64716067-5EEB3502-1E22-4D3C-92ED-17096F667A35 @default.
- Q64716067 P31 Q64716067-16493366-70A0-4F5C-B161-22D0ACF62925 @default.
- Q64716067 P580 Q64716067-6A60DD77-1DDB-4F58-B22C-F66694831981 @default.
- Q64716067 P582 Q64716067-C1EEB462-9B93-4247-982B-631C97721B34 @default.
- Q64716067 P6099 Q64716067-8ABA55F9-5CCA-4F35-A8EA-3E8AA1510632 @default.
- Q64716067 P8363 Q64716067-664006E6-19A3-4642-BB4F-B8AD7D1EC603 @default.
- Q64716067 P859 Q64716067-BB08E366-9649-4B87-BD6C-C73484521074 @default.
- Q64716067 P1050 Q29496 @default.
- Q64716067 P1132 "+129" @default.
- Q64716067 P1476 "Front-line Treatment of Philadelphia Positive (Ph Pos), BCRABL Positive, Chronic Myeloid Leukemia (CML) With Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imotinib) A Phase II Exploratory Multicentric Centre." @default.
- Q64716067 P17 Q38 @default.
- Q64716067 P1813 "CML0408" @default.
- Q64716067 P2899 "+18" @default.
- Q64716067 P3098 "NCT00769327" @default.
- Q64716067 P31 Q30612 @default.
- Q64716067 P580 "2009-02-01T00:00:00Z" @default.
- Q64716067 P582 "2014-10-01T00:00:00Z" @default.
- Q64716067 P6099 Q42824440 @default.
- Q64716067 P8363 Q78089383 @default.
- Q64716067 P859 Q3764428 @default.